Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 568

Corporates find Radicle agtech solution

Bayer and DuPont have joined a consortium of investors to co-found a $15m agtech-focused accelerator fund dubbed Radicle, which has closed $6m so far.

Jun 24, 2016

Vorwerk makes Juniqe investment in $15.9m round

Direct selling company Vorwerk's corporate venturing vehicle made its second investment in Juniqe as part of the affordable art platform's series B round.

Jun 23, 2016

Russian universities set up $13.8m fund

Novosibirsk State University and Tomsk State University of Control Systems and Radioelectronics join forces to create a $13.8m venture fund.

Jun 23, 2016

Groningen boosts tech transfer fund to $35m

EIF invests in the tech transfer fund of Groningen University and UMCG to support innovation in northern areas of the Netherlands and the healthy ageing sector.

Jun 23, 2016

Cyberowl watches over $212,000

Mercia Fund Management aims to keep businesses safe online by investing $212,000 in Coventry University spinout Cyberowl.

Jun 22, 2016

Deutsche Boerse sets up corporate venturing unit

The stock market operator has set up a strategic investment unit called DB1 Ventures to manage its VC portfolio and fund new companies.

Jun 22, 2016

Number26 counts to $40m

Axel Springer-backed mobile banking service provider Number26 has closed a series B round and boosted its total funding to approximately $53m.

Jun 22, 2016

CaterWings takes flight with corporate backing

Tengelmann and Rocket Internet were among the investors in a $6.8m round for the catering marketplace startup, launched in autumn last year.

Jun 21, 2016

EIF boosts $38m Thuja healthcare fund

Thuja Capital Healthcare Fund II will support commercialisation of research at Utrecht University, University Medical Center Utrecht and Radboud University Medical Center.

Jun 21, 2016

F2G grows on investors to raise $60m

Novo and existing shareholder Novartis have contributed to a funding round that will allow antifungal drug developer F2G to advance its lead candidate.

Jun 21, 2016
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here